Literature DB >> 66979

Isolation and identification of human lung tumor-associated antigens.

R W Veltri, H F Mengoli, P E Maxim, S Westfall, J M Gopo, C W Hauang, P M Sprinkle.   

Abstract

Three human lung tumor-associated antigens (TAA's) have been identified in soluble and membrane-solubilized extracts of human squamous cell lung carcinoma with the use of antisera raised in rabbits. The antigens were identified and partially characterized by means of an agarose adsorption technique. These antigens, termed lung TAA's 1,2, and 3, are all soluble in 50% ammonium sulfate, are antigenically distinct, and do not cross-react with carcinoembryonic antigen or alpha-fetoprotein. Lung TAA's 1 and 2 are oncofetal antigens demonstrable in soluble extracts from 24-week-old but not from 26-week-old fetal lungs. Rabbit antibodies to these lung TAA's were not adsorbed by types A, B, and O human red blood cells, serum proteins as well as soluble or insoluble lung preparations. Of several commercial antisera to human proteins, none cross-reacted with lung TTA 1, but anti-human liver ferritin cross-reacted with lung TAA 2, and anti-human lactoferrin cross-reacted with lung TAA 3. Lung TAA 1 was partially adsorbed and cross-reacted with certain normal serum or plasma preparations used and appears to be a normal serum protein in Cohn Fraction IV-4. Lung TAA 2 and 3 appear only in lung tumor-soluble extracts, whereas the lung TAA 1 was demonstrable in soluble extracts of breast, colon, cervical and head and neck carcinoma. All may be tumor markers of value in immunodiagnosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66979

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.

Authors:  S Hirohashi; H Clausen; T Yamada; Y Shimosato; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

Authors:  A C Hollinshead; T H Stewart
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct

3.  An improved antigenic marker of human lung carcinomas and its use in radioimmunoassays.

Authors:  A Wolf; M Micksche; H Bauer
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

4.  Collaborative study of bronchial tumour-associated antigens.

Authors:  J N Gennings; K D Bagshawe; N H Axelsen; P Sizaret
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

5.  A human tumour-associated membrane antigen from squamous-cell carcinoma of the lung.

Authors:  R W Veltri; P E Maxim; J M Boehlecke
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

6.  A tumour-associated antigen from the pleural effusion of patients with squamous-cell carcinoma of lung.

Authors:  A Wolf
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.